Strategies in recommending influenza vaccination in Europe and US

Caterina Rizzo, Giovanni Rezza, Walter Ricciardi

Research output: Contribution to journalReview article

15 Citations (Scopus)

Abstract

There is potential for influenza vaccine programmes to make a substantial impact on the disease burden. The World Health Organization (WHO) has identified young children, pregnant women, persons with chronic medical conditions, and the elderly as being at risk for severe influenza disease and therefore important groups to be considered for influenza vaccination. Applying the methodology of scoping review of grey and scientific literature we described the European and the US approach to influenza vaccine prevention. Although vaccination remains the most effective means of reducing the incidence and severity of influenza, vaccine uptake in many European countries remains suboptimal (i.e. 45.5% in the elderly, 24% in health care workers, from 49.8% in patients with chronic medical conditions, median 23.6% in pregnant women) and vaccine strategies are not harmonized in particular with regard to vaccinating healthy children. Whereas in the US the vaccine strategies are more standardized across states and vaccine coverage are higher than those reported in EU on average. The integration of different strategies is crucial in order to increase influenza vaccine coverage: public health authorities should encourage healthcare workers to vaccinate themselves, as target category, and to recommend seasonal influenza vaccination to people in the target groups; there should also be structured communication campaigns on influenza and influenza vaccines, directed specifically at these target groups, and an adequate and sustainable funding is also an important factor to achieve higher vaccination coverage rates.

Original languageEnglish
Pages (from-to)693-698
Number of pages6
JournalHuman Vaccines and Immunotherapeutics
Volume14
Issue number3
DOIs
Publication statusPublished - Mar 4 2018

Fingerprint

Influenza Vaccines
Human Influenza
Vaccination
Vaccines
Pregnant Women
Delivery of Health Care
Literature
Public Health
Communication
Incidence

Keywords

  • Europe
  • influenza
  • Influenza vaccine
  • United States
  • vaccination strategies

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology
  • Pharmacology

Cite this

Strategies in recommending influenza vaccination in Europe and US. / Rizzo, Caterina; Rezza, Giovanni; Ricciardi, Walter.

In: Human Vaccines and Immunotherapeutics, Vol. 14, No. 3, 04.03.2018, p. 693-698.

Research output: Contribution to journalReview article

@article{0373f5fbe1824e82aa8d27dea8638888,
title = "Strategies in recommending influenza vaccination in Europe and US",
abstract = "There is potential for influenza vaccine programmes to make a substantial impact on the disease burden. The World Health Organization (WHO) has identified young children, pregnant women, persons with chronic medical conditions, and the elderly as being at risk for severe influenza disease and therefore important groups to be considered for influenza vaccination. Applying the methodology of scoping review of grey and scientific literature we described the European and the US approach to influenza vaccine prevention. Although vaccination remains the most effective means of reducing the incidence and severity of influenza, vaccine uptake in many European countries remains suboptimal (i.e. 45.5{\%} in the elderly, 24{\%} in health care workers, from 49.8{\%} in patients with chronic medical conditions, median 23.6{\%} in pregnant women) and vaccine strategies are not harmonized in particular with regard to vaccinating healthy children. Whereas in the US the vaccine strategies are more standardized across states and vaccine coverage are higher than those reported in EU on average. The integration of different strategies is crucial in order to increase influenza vaccine coverage: public health authorities should encourage healthcare workers to vaccinate themselves, as target category, and to recommend seasonal influenza vaccination to people in the target groups; there should also be structured communication campaigns on influenza and influenza vaccines, directed specifically at these target groups, and an adequate and sustainable funding is also an important factor to achieve higher vaccination coverage rates.",
keywords = "Europe, influenza, Influenza vaccine, United States, vaccination strategies",
author = "Caterina Rizzo and Giovanni Rezza and Walter Ricciardi",
year = "2018",
month = "3",
day = "4",
doi = "10.1080/21645515.2017.1367463",
language = "English",
volume = "14",
pages = "693--698",
journal = "Human Vaccines and Immunotherapeutics",
issn = "2164-5515",
publisher = "Taylor and Francis Inc.",
number = "3",

}

TY - JOUR

T1 - Strategies in recommending influenza vaccination in Europe and US

AU - Rizzo, Caterina

AU - Rezza, Giovanni

AU - Ricciardi, Walter

PY - 2018/3/4

Y1 - 2018/3/4

N2 - There is potential for influenza vaccine programmes to make a substantial impact on the disease burden. The World Health Organization (WHO) has identified young children, pregnant women, persons with chronic medical conditions, and the elderly as being at risk for severe influenza disease and therefore important groups to be considered for influenza vaccination. Applying the methodology of scoping review of grey and scientific literature we described the European and the US approach to influenza vaccine prevention. Although vaccination remains the most effective means of reducing the incidence and severity of influenza, vaccine uptake in many European countries remains suboptimal (i.e. 45.5% in the elderly, 24% in health care workers, from 49.8% in patients with chronic medical conditions, median 23.6% in pregnant women) and vaccine strategies are not harmonized in particular with regard to vaccinating healthy children. Whereas in the US the vaccine strategies are more standardized across states and vaccine coverage are higher than those reported in EU on average. The integration of different strategies is crucial in order to increase influenza vaccine coverage: public health authorities should encourage healthcare workers to vaccinate themselves, as target category, and to recommend seasonal influenza vaccination to people in the target groups; there should also be structured communication campaigns on influenza and influenza vaccines, directed specifically at these target groups, and an adequate and sustainable funding is also an important factor to achieve higher vaccination coverage rates.

AB - There is potential for influenza vaccine programmes to make a substantial impact on the disease burden. The World Health Organization (WHO) has identified young children, pregnant women, persons with chronic medical conditions, and the elderly as being at risk for severe influenza disease and therefore important groups to be considered for influenza vaccination. Applying the methodology of scoping review of grey and scientific literature we described the European and the US approach to influenza vaccine prevention. Although vaccination remains the most effective means of reducing the incidence and severity of influenza, vaccine uptake in many European countries remains suboptimal (i.e. 45.5% in the elderly, 24% in health care workers, from 49.8% in patients with chronic medical conditions, median 23.6% in pregnant women) and vaccine strategies are not harmonized in particular with regard to vaccinating healthy children. Whereas in the US the vaccine strategies are more standardized across states and vaccine coverage are higher than those reported in EU on average. The integration of different strategies is crucial in order to increase influenza vaccine coverage: public health authorities should encourage healthcare workers to vaccinate themselves, as target category, and to recommend seasonal influenza vaccination to people in the target groups; there should also be structured communication campaigns on influenza and influenza vaccines, directed specifically at these target groups, and an adequate and sustainable funding is also an important factor to achieve higher vaccination coverage rates.

KW - Europe

KW - influenza

KW - Influenza vaccine

KW - United States

KW - vaccination strategies

UR - http://www.scopus.com/inward/record.url?scp=85044202630&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85044202630&partnerID=8YFLogxK

U2 - 10.1080/21645515.2017.1367463

DO - 10.1080/21645515.2017.1367463

M3 - Review article

C2 - 28922083

AN - SCOPUS:85044202630

VL - 14

SP - 693

EP - 698

JO - Human Vaccines and Immunotherapeutics

JF - Human Vaccines and Immunotherapeutics

SN - 2164-5515

IS - 3

ER -